Comparative testing of the potency of different PPD preparations

Developments in Biological Standardization
|January 1, 1986
PubMed

Insights

Tuberculin Purified Protein Derivative (PPD) potency from M. tuberculosis and M. bovis was tested. Fractionation and purification did not yield PPD with significantly greater potency for improved tuberculosis diagnostics.

Area of Science:

  • Immunology
  • Microbiology
  • Tuberculosis Diagnostics

Background:

  • Tuberculosis remains a global health challenge, necessitating improved diagnostic tools.
  • Purified Protein Derivative (PPD) is a key component in tuberculin skin tests for diagnosing tuberculosis.
  • Evaluating PPD potency from different Mycobacterium species is crucial for diagnostic accuracy.

Purpose of the Study:

  • To investigate the potency of PPD preparations from M. tuberculosis and M. bovis.
  • To assess the efficacy of fractionating and purifying PPD for enhanced diagnostic potential.
  • To determine if PPD from different mycobacteria or purified fractions offer superior potency.

Main Methods:

  • Guinea-pig tests were employed to evaluate PPD potency.
  • Animals were immunized with mycobacterium powder (M. tuberculosis, M. bovis, or combined) in liquid paraffin oil, and with BCG vaccine.
  • Mixed PPD was fractionated using SEPHAROSE 6 B and SEPHACRYL S 200 columns, with potency assessed via guinea-pig tests and protein N content.

Main Results:

  • No significant difference in potency was observed between homologous and heterologous PPD, irrespective of the immunization method.
  • Fractionation of mixed PPD did not yield fractions with significantly greater potency compared to the non-fractionated material.
  • Calculated International Units (IU) based on protein N content did not reveal enhanced potency in fractions.

Conclusions:

  • Current PPD preparations from M. tuberculosis and M. bovis, even when fractionated, do not demonstrate significantly enhanced potency in guinea-pig models.
  • Improving tuberculosis diagnostics may require further immunochemical purification of tuberculin preparations.
  • Extensive testing of purified tuberculin materials in human subjects is recommended for future diagnostic advancements.